❌

Normal view

OpenS2S: Advancing Fully Open-Source End-to-End Empathetic Large Speech Language Model

arXiv:2507.05177v3 Announce Type: replace-cross Abstract: Empathetic interaction is a cornerstone of human-machine communication, due to the need for understanding speech enriched with paralinguistic cues and generating emotional and expressive responses. However, the most powerful empathetic LSLMs are increasingly closed off, leaving the crucial details about the architecture, data and development opaque to researchers. Given the critical need for transparent research into the LSLMs and empathetic behavior, we present OpenS2S, a fully open-source, transparent and end-to-end LSLM designed to enable empathetic speech interactions. Based on our empathetic speech-to-text model BLSP-Emo, OpenS2S further employs a streaming interleaved decoding architecture to achieve low-latency speech generation. To facilitate end-to-end training, OpenS2S incorporates an automated data construction pipeline that synthesizes diverse, high-quality empathetic speech dialogues at low cost. By leveraging large language models to generate empathetic content and controllable text-to-speech systems to introduce speaker and emotional variation, we construct a scalable training corpus with rich paralinguistic diversity and minimal human supervision. We release the fully open-source OpenS2S model, including the dataset, model weights, pre-training and fine-tuning codes, to empower the broader research community and accelerate innovation in empathetic speech systems. The project webpage can be accessed at https://casia-lm.github.io/OpenS2S

LcProt: Proteomics-based identification of plasma biomarkers for lung cancer multievent, a multicentre study

Clin Transl Med. 2025 Jan;15(1):e70160. doi: 10.1002/ctm2.70160.

ABSTRACT

BACKGROUND: Plasma protein has gained prominence in the non-invasive predicting of lung cancer. We utilised Zeolite Zotero NaY-based plasma proteomics to investigate its potential for multiple event predicting, including lung cancer diagnosis (task #1), lymph node metastasis detection (task #2) and tumour‒node‒metastasis (TNM) staging (task #3).

METHODS: A total of 4703 plasma proteins were quantified from 241 participants based on a prospective cohort of 2757 participants. An additional 46 participants from external prospective cohort of 735 participants were used for validation. Feature selection was performed using differential expressed protein analysis, area under curve (AUC) evaluation and least absolute shrinkage and selection operator (LASSO) regression. Random forest was used for multitask model construction based on the key proteins. Feature importance was interpreted using Shapley additive explanations (SHAP) algorithm.

RESULTS: For task #1, 10 proteins panel showed an AUC of .87 (.77‒.97) in the external validation. After integrating clinical factors, a significant increase diagnostic accuracy was observed with AUC of .91 (.85‒.98). For task #2, nine proteins panel achieved an AUC of .88 (.80‒.96), integration model showed an increase diagnostic accuracy with AUC of .90 (.85‒.97). For task #3, 10 proteins panel showed an AUC of .88 (.74‒.96) for stage I, .92 (.84‒.97) for stage II, .88 (.76‒.96) for stage III and .99 (.98‒.99) for stage IV in the integration model.

CONCLUSIONS: This study comprehensively profiled the NaY-based plasma proteome biomarker, laying the foundation for a high-performance blood test for predicting multiple events in lung cancer.

KEY POINTS: Our study developed an innovative nanomaterial, Zeolite NaY, which addressed the masking effect and improved the depth of the proteome. The performance of NaY-based plasma proteomics as a preclinical diagnostic tool was validated through both internal and external cohort. Furthermore, we explored the different patterns of plasma protein changes during the progression of lung cancer and used the explanations method to elucidate the roles of proteins in the multitask predictive model.

PMID:39783847 | PMC:PMC11714244 | DOI:10.1002/ctm2.70160

Scientific discovery in the age of artificial intelligence

Nature, Published online: 02 August 2023; doi:10.1038/s41586-023-06221-2

The advances in artificial intelligence over the past decade are examined, with a discussion on how artificial intelligence systems can aid the scientific process and the central issues that remain despite advances.
❌